📰 Multiple Sclerosis Centers News
Page 2 - Multiple Sclerosis Centers News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple Sclerosis Centers. Real-time updates on events, politics, business and more.
June 22, 2023
Mindfulness-based stress reduction for patients with multiple sclerosis (MS) can lead to improvements in the silent symptoms of MS.
June 15, 2023
In the ongoing absence of a reliable biomarker for multiple sclerosis, misdiagnosis is a common, and persistent, problem that potentially puts patients at prolonged and unnecessary risk.
June 15, 2023
Hispanic and Black/African American patients are often overlooked in studies that assess mental health and quality of life in MS.
June 13, 2023
Fatigue related to multiple sclerosis impacts cognition in patients with relapsing MS, compared with healthy individuals.
June 9, 2023
Phase 2 data on the investigational drug frexalimab show favorable safety and significant reduction in new T1 brain lesions in relapsing MS.
June 7, 2023
People with relapsing MS who experienced disease activity while on oral therapies had less disease activity after switching to Kesimpta.
June 6, 2023
Multiple treatment transitions in patients with NMOSD are associated with increased neurological harm, including increased relapse risk and disease progression.
June 5, 2023
Analyses of protein levels in the blood can be used to identify groups of MS patients with distinct clinical features, which may improve care.
June 5, 2023
The use of the monoclonal antibody satralizumab for the long-term treatment of neuromyelitis optica spectrum disorder provides sustained freedom from relapse with no new safety concerns over 5 years.
June 2, 2023
The European Commission has approved Briumvi to treat people with relapsing forms of MS who have active disease.